Literature DB >> 3021516

Role of antecedent mumps and reovirus infections on the development of type 1 (insulin-dependent) diabetes.

A Toniolo, P G Conaldi, C Garzelli, G Benedettini, G Federico, G Saggese, R Vettor, G Federspil.   

Abstract

Type 1 diabetes mellitus is thought to derive from organ-specific autoimmune reactions, probably triggered by environmental factors. In view of the possible involvement of mumps virus and reoviruses in the pathogenesis of autoimmune endocrine disease, serum antibody levels to these viruses were measured in newly-diagnosed diabetic patients aged 5 to 25 years and in matched control subjects. Diabetic patients showed a significantly lower prevalence and reduced titers of antibodies to mumps and reoviruses. By contrast, the antibody response to measles virus (a non-diabetogenic agent) was remarkably similar in the two groups. It is suggested that individuals with an impaired humoral response to some viral agents are at increased risk of developing diabetes when exposed to pancreotropic viruses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3021516     DOI: 10.1007/bf00234091

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  30 in total

1.  The causes of diabetes.

Authors:  A L Notkins
Journal:  Sci Am       Date:  1979-11       Impact factor: 2.142

2.  Virus-induced diabetes mellitus: reovirus infection of pancreatic beta cells in mice.

Authors:  T Onodera; A B Jenson; J W Yoon; A L Notkins
Journal:  Science       Date:  1978-08-11       Impact factor: 47.728

3.  Prevalence of islet cell antibodies (ICA) and islet cell surface antibodies (ICSA) in children and adolescents with antecedent mumps infection).

Authors:  K P Ratzmann; J Strese; I Rjasanowski; S Witt; H Keilacker
Journal:  Exp Clin Endocrinol       Date:  1984-04

4.  Diabetes--a possible autoimmune disease.

Authors:  J L Marx
Journal:  Science       Date:  1984-09-21       Impact factor: 47.728

5.  Comparison of nonspecific reactivity in indirect and reverse immunoassays for measles and mumps immunoglobulin M antibodies.

Authors:  H Tuokko
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

Review 6.  The epidemiology of insulin dependent diabetes with particular reference to the relationship of virus infection to its etiology.

Authors:  D R Gamble
Journal:  Epidemiol Rev       Date:  1980       Impact factor: 6.222

7.  The interaction of a series of hybridoma IgGs with reovirus particles. Demonstration that the core protein lambda 2 is exposed on the particle surface.

Authors:  E C Hayes; P W Lee; S E Miller; W K Joklik
Journal:  Virology       Date:  1981-01-15       Impact factor: 3.616

8.  Relation of antecedent illness to development of diabetes in children.

Authors:  D R Gamble
Journal:  Br Med J       Date:  1980-07-12

9.  Reduced Coxsackie antibody titres in type 1 (insulin-dependent) diabetic patients presenting during an outbreak of Coxsackie B3 and B4 infection.

Authors:  J P Palmer; M K Cooney; R H Ward; J A Hansen; J B Brodsky; C G Ray; J R Crossley; C M Asplin; R H Williams
Journal:  Diabetologia       Date:  1982-06       Impact factor: 10.122

10.  Virus-induced diabetes mellitus. XX. Polyendocrinopathy and autoimmunity.

Authors:  T Onodera; A Toniolo; U R Ray; A B Jenson; R A Knazek; A L Notkins
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

View more
  2 in total

1.  No evidence of abnormal regulation of antibody response to coxsackievirus B4 antigen in prediabetic children.

Authors:  L Heino; M Lönnrot; M Knip; A Kupila; S Erkkilä; A Toivonen; P Vähäsalo; J Ilonen; O Simell; H Hyöty
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

2.  Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Childhood Diabetes in Finland Study Group.

Authors:  H Hyöty; M Hiltunen; A Reunanen; P Leinikki; T Vesikari; R Lounamaa; J Tuomilehto; H K Akerblom
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.